|
Masahiro Kino-oka PhD
Professor
Osaka University
Osaka
Japan
|
Masa (Masahiro KINO-OKA) is one of leaders in the field of manufacturing for cell and tissue products; individuals who seem able to contribute to the standardization of the cell processing facility and bioreactor. His current research interests are “Bioprocess engineering” to establish the cell and tissue manufacturing system including the fields of “Bioreaction Engineering”, “Bioprocess design”, and “Stem Cell Engineering”, advocating “cell manufacturability” which leads to stable and cost-saving system for manufacturing of stem cells.
Currently, he started new projects for manufacturing including facility design of cell and tissue processing (Development of cell manufacturing and processing system for industrialization of regenerative medicine by Japan Agency for Medical Research and Development (AMED) (2014.4-2019.3)) for development of guidance for cell and tissue processing (good cell and tissue practice, GCTP). To develop the facility, he has joined to ISO to be international member in ISO TC198 / WG9 for aseptic processing as well as ISO TC276 / WG4 for bioprocessing. In addition, he becomes board of directors of the Japanese Society for Regenerative Medicine (JSRM) and Health Science Council member in Minister of Health Labor and Welfare (MHLW), collaborating with regulatory site of Japanese FDA (PMDA) to establish guideline for aseptic cell processing.
Masa also has established “Research Base for Cell Manufacturability” in Osaka University since 2021 to develop practical system for cell manufacturing, guidance for regulation and standard as well as human resources for process design. Several companies gather to open their laboratories inside Osaka University, making up the core of the consortium management.
Currently, he started new projects for manufacturing including facility design of cell and tissue processing (Development of cell manufacturing and processing system for industrialization of regenerative medicine by Japan Agency for Medical Research and Development (AMED) (2014.4-2019.3)) for development of guidance for cell and tissue processing (good cell and tissue practice, GCTP). To develop the facility, he has joined to ISO to be international member in ISO TC198 / WG9 for aseptic processing as well as ISO TC276 / WG4 for bioprocessing. In addition, he becomes board of directors of the Japanese Society for Regenerative Medicine (JSRM) and Health Science Council member in Minister of Health Labor and Welfare (MHLW), collaborating with regulatory site of Japanese FDA (PMDA) to establish guideline for aseptic cell processing.
Masa also has established “Research Base for Cell Manufacturability” in Osaka University since 2021 to develop practical system for cell manufacturing, guidance for regulation and standard as well as human resources for process design. Several companies gather to open their laboratories inside Osaka University, making up the core of the consortium management.